0001209191-23-044961.txt : 20230808
0001209191-23-044961.hdr.sgml : 20230808
20230808160952
ACCESSION NUMBER: 0001209191-23-044961
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20230804
FILED AS OF DATE: 20230808
DATE AS OF CHANGE: 20230808
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Baranick Brian
CENTRAL INDEX KEY: 0001941313
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35092
FILM NUMBER: 231151359
MAIL ADDRESS:
STREET 1: 441 CHARMANY DRIVE
CITY: MADISON
STATE: WI
ZIP: 53719
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: EXACT SCIENCES CORP
CENTRAL INDEX KEY: 0001124140
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 204782291
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5505 ENDEAVOR LANE
CITY: MADISON
STATE: WI
ZIP: 53719
BUSINESS PHONE: 608-284-5700
MAIL ADDRESS:
STREET 1: 5505 ENDEAVOR LANE
CITY: MADISON
STATE: WI
ZIP: 53719
FORMER COMPANY:
FORMER CONFORMED NAME: EXACT CORP
DATE OF NAME CHANGE: 20000919
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-08-04
0
0001124140
EXACT SCIENCES CORP
EXAS
0001941313
Baranick Brian
C/O EXACT SCIENCES CORP.
5505 ENDEAVOR LANE
MADISON
WI
53719
0
1
0
0
Gen. Mgr., Precision Oncology
1
Common Stock
2023-08-04
4
M
0
2712
0.00
A
10221
D
Common Stock
2023-08-07
4
S
0
1350
85.04
D
8871
D
Common Stock
298
I
Held in 401(k) Plan
Restricted Stock Units
2023-08-04
4
M
0
2712
0.00
D
Common Stock
2712
2712
D
Represents shares of common stock received upon vesting of a restricted stock unit award.
Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan, entered into June 26, 2020, to pay withholding taxes due in connection with the vesting of certain restricted stock units on August 4, 2023.
In addition to the shares of Common Stock reported on this Form 4, which total 9,169 shares, Mr. Baranick also holds, in the aggregate, an additional 36,932 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.
Each restricted stock unit represents a contingent right to receive one share of common stock.
Represents a restricted stock unit award that partially vested on August 4, 2023. The restricted stock units vest in four equal annual installments beginning on August 4, 2021.
Exhibit List
Exhibit 24 - Power of Attorney
/s/ Brian Baranick by Mark R. Busch, attorney-in-fact
2023-08-08
EX-24
2
poa.txt
POA DOCUMENT
POWER OF ATTORNEY
The undersigned hereby constitutes and appoints each of D. Scott Coward, Mark
Busch and James Herriott, signing singly, as the undersigned's true and lawful
attorney-in-fact to:
(1) execute for and on behalf of the undersigned, in the undersigned's capacity
as a director or officer of Exact Sciences Corporation (the "Company"), Forms 3,
4 and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934
and the rules thereunder (the "Exchange Act"), as well as the Form ID to obtain
and/or renew EDGAR codes for use in connection with the filing of Forms 3, 4 and
5 and any other related documentation;
(2) do and perform any and all acts for and on behalf of the undersigned which
may be necessary or desirable to complete and execute any such Forms 3, 4 or 5,
Form ID or other related documentation, complete and execute any amendment or
amendments thereto, and timely file such forms or documentation with the United
States Securities and Exchange Commission and any stock exchange or similar
authority;
(3) take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of benefit to,
in the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and shall
contain such terms and conditions as such attorney-in-fact may approve in such
attorney-in-fact's discretion; and
(4) in connection with the preparation and filing of Forms 3, 4 and 5, seek or
obtain, as the undersigned's attorney-in-fact and on the undersigned's behalf,
information regarding transactions in the Company's securities from any third
party, including brokers, employee benefit plan administrators and trustees, and
the undersigned hereby authorizes any such person to release any such
information to such attorney-in-fact and approves and ratifies any such release
of information.
The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in connection with the exercise of any of the
rights and powers herein granted, as fully to all intents and purposes as the
undersigned might or could do if personally present, with full power of
substitution or revocation, hereby ratifying and confirming all that such
attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall
lawfully do or cause to be done by virtue of this Power of Attorney and the
rights and powers herein granted. The undersigned acknowledges that the
foregoing attorneys-in-fact, in serving in such capacity at the request of the
undersigned, are not assuming, nor is the Company assuming, any of the
undersigned's responsibilities to comply with Section 16 of the Exchange Act.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact.
This Power of Attorney does not relieve the undersigned from responsibility for
compliance with the undersigned's obligations under the Exchange Act, including,
without limitation, the reporting requirements under Section 16 of the Exchange
Act. Additionally, although pursuant to this Power of Attorney the Company will
use commercially reasonable best efforts to timely and accurately file Section
16 reports on behalf of the undersigned, the Company does not represent or
warrant that it will be able to in all cases timely and accurately file Section
16 reports on behalf of the undersigned due to various factors, including, but
not limited to, the shorter deadlines mandated by the Sarbanes-Oxley Act of
2002, possible time zone differences between the Company and the undersigned and
the Company's need to rely on other parties for information, including the
undersigned and brokers of the undersigned.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of July 26, 2022.
/s/ Brian Baranick
Brian Baranick